ANI appoints Henry Gosebruch to board
ANI Pharmaceuticals appointed Henry Gosebruch to its board to bolster business development capabilities amid its transformation into a Rare Disease company, while also announcing the resignation of board member Muthusamy Shanmugam.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day